Company: OCEA
Filing Date: 2025-03-10
Form Type: DEFA14A
Source: 0001493152-25-009713
Chunk: 1

Company: Ocean Biomedical, Inc.
Filing Date: 2025-03-10
Form: DEFA14A
Chunk 1
---
 on Which Registered |

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (CFR §240.12b-2 of this chapter). Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Resignation of a Director

On March 4, 2025, Amy Griffith informed the Board of Directors of the Company that she will not be standing for reelection and is resigning from the Board as of the Annual Meeting.

The Company is working to find two independent directors to fill vacancies being created by the previously announced determination to not stand for reelection by William Ownes, Jack Elias, Suren Ajjarpu and Michelle Berry.

<div align='center'>SIGNATURE</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 10, 2025

| OCEAN            
 BIOMEDICAL, INC. |                   |
| By:              | /s/               
 Jolie Kahn        |
|                  | Jolie             
 Kahn              |
|                  | Chief             
 Financial Officer |